Neurogene Inc. (NGNE) stock
NGNENasdaqPharmaceutical PreparationsFiscal year ends December 31
$23.10−0.20 (-0.86%)
Close on Nov 17, 2026Market cap $462.26MP/E –Yield –
Neurogene price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Neurogene's price to sales ratio was 240.9× on Apr 30, 2025.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Apr 30, 2025 | 240.9× | +230.8 |
| 2019 | Apr 30, 2019 | 10.1× | – |
See a number that looks wrong?